Janus kinase (JAK) and STAT (JAK/STAT) signaling plays an important role in keratinocyte associated skin disease and pathway inhibitors show efficacy in other disease such as psoriasis and atopic dermatitis (89). Here, SOAT1 is linked to atopic eczema.